Ryan A McTaggart

TL;DR: Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical Therapy alone among patients with proximal middle‐cerebral‐artery or internal‐carotid‐arterY occlusion and a region of tissue that was ischeMIC but not yet infarcted.

TL;DR: Nerinetide did not improve the proportion of patients achieving good clinical outcomes after endovascular thrombectomy compared with patients receiving placebo, and this trial is registered with ClinicalTrials.gov, NCT02930018.

TL;DR: As a naturally occurring interconvertible form of AA with BBB permeability, DHA represents a promising pharmacological therapy for stroke based on its effects in this model of cerebral ischemia.

TL;DR: It is demonstrated that CD39 exerts a protective thromboregulatory function in stroke by reconstituting these mice, restoring postischemic cerebral perfusion and rescuing them from cerebral injury.

TL;DR: Sirolimus appears to prolong DGF, and it may not be the optimal immunosuppressive choice in the DGF setting, but it retained its profound negative association with time to graft function in all multivariate models.